CN EN
86-400-8228-027
Cn En
Phone
Phone:+86-400-8228-027
WeChat
Contact Us
iPSC Gene Editing
We adopt advanced gene editing technologies such as CRISPR-Cas9, and exclusively employ non-integrating gene editing workflows throughout the entire process.This means that we achieve permanent modification of the target gene through precise genetic manipulation, while avoiding the integration of exogenous vector DNA into the genome. This fundamentally eliminates the risk of tumorigenicity and other potential safety hazards associated with random genomic integration, ensuring that the edited cell lines you obtain are safer, more reliable, and compliant with stringent preclinical research standards.
Service Advantages
Extensive Service Experience
Somax Biotechnology has been providing gene editing technical services since 2015 and has accumulated extensive hands-on experience in the field.
Excellent Technical Strength
Based on non-integrating gene editing technology, we provide safe, efficient and reliable gene editing solutions.
Diversified Service Portfolio
In addition to routine cell line gene editing services, Somax Bio also provides specialized technical services including iPSC line-based gene editing and lncRNA gene editing.
Service Details

Service Item

Service Type

Deliverables

iPSC Gene Editing Services

Coding gene knockout (frameshift mutation)

a vial of biallelic gene knockout cell line + final project report

Point mutation (<20bp fragment)

a vial of heterozygous point mutation cell line + final project report

Gene knock-in (20bp-2kb fragment)

a vial of heterozygous knock-in cell line + final project report

 

Service Features:

Featured Gene Editing Services: Specialized lncRNA knockout services and iPSC-specific gene editing services are available.

No Exogenous Gene Integration: Delivered via RNP electroporation, avoiding random insertion mutations caused by lentiviral vectors and off-target effects caused by CRISPR/Cas9 integration.

High Efficiency and Short Turnaround Time: Gene knockout projects can be completed in as little as 2 months, with 100% correctly modified monoclonal cell lines delivered.

Professional Services: One-to-one communication with dedicated technical support, a detailed feasibility analysis report prior to project kickoff, and full professional technical support throughout the project cycle.

Follow-up Supporting Technical Services: RNA-seq services are available to support mechanistic research such as the identification of relevant signaling pathways.

Case Introduction:

Case│iPSC CYFIP2 c.259C>T Point Mutation | Partner: Hunan Provincial Maternal and Child Health Care Hospital

Result Verification: The sequencing results of the mixed cells are shown below (sequenced with reverse primer, the base selected in blue is the c.259C>T target mutation site). It can be seen from the figure that after electroporation of sgCYFIP2, a red peak T appears at the c.259C>T position, indicating that a certain amount of "c.259C>T" was mutated back to "T" in the mixed cells. Subsequently, single clone picking and identification were performed, and the mutant cell line was obtained in a single round of screening.